Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

1.5K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.5K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

2.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Presence of EBV and HHV-7 Genomic Sequences in Saliva and Virus-Specific Antibodies in Sera of Oral Lichen Planus and Aphthous Stomatitis Patients: A Comparative Observational Study.

Viruses·2026
Same author

Digital Approaches for Managing Brain Fog in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Interventions, Monitoring, and Future Directions.

Life (Basel, Switzerland)·2026
Same author

Myalgic encephalomyelitis/chronic fatigue syndrome and fibromyalgia - overlap, differences, and emerging insights.

Journal of translational medicine·2026
Same author

Co-Occurrence of High-Risk Human Papillomavirus and Herpesviruses Infections in Female Kidney Transplant Recipients: A Prospective One-Year Study.

Medicina (Kaunas, Lithuania)·2026
Same author

Reframing Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Biological Basis of Disease and Recommendations for Supporting Patients.

Healthcare (Basel, Switzerland)·2025
Same author

Two-dimensional shear wave elastography for assessing liver, spleen, and kidneys in healthy newborns.

Journal of ultrasonography·2025

Related Experiment Video

Updated: Oct 15, 2025

Sagittal Plane Kinematic Gait Analysis in C57BL/6 Mice Subjected to MOG35-55 Induced Experimental Autoimmune Encephalomyelitis
13:02

Sagittal Plane Kinematic Gait Analysis in C57BL/6 Mice Subjected to MOG35-55 Induced Experimental Autoimmune Encephalomyelitis

Published on: November 4, 2017

8.8K

Turning a Corner in ME/CFS Research.

Derek F H Pheby1, Kenneth J Friedman2, Modra Murovska3

  • 1Society and Health, Buckinghamshire New University, High Wycombe HP11 2JZ, UK.

Medicina (Kaunas, Lithuania)
|October 23, 2021
PubMed
Summary

This research explores myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), addressing its nature, diagnostic challenges, and patient impact. It proposes a new category, post-active phase of infection syndromes (PAPIS), for conditions like ME/CFS and Long COVID.

Keywords:
ME/CFSchronic fatigue syndromeclinical careguidelineknowledge and understandingmyalgic encephalomyelitisquality of life

More Related Videos

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

3.9K
Muscle Velocity Recovery Cycles to Examine Muscle Membrane Properties
08:27

Muscle Velocity Recovery Cycles to Examine Muscle Membrane Properties

Published on: February 19, 2020

14.4K

Related Experiment Videos

Last Updated: Oct 15, 2025

Sagittal Plane Kinematic Gait Analysis in C57BL/6 Mice Subjected to MOG35-55 Induced Experimental Autoimmune Encephalomyelitis
13:02

Sagittal Plane Kinematic Gait Analysis in C57BL/6 Mice Subjected to MOG35-55 Induced Experimental Autoimmune Encephalomyelitis

Published on: November 4, 2017

8.8K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

3.9K
Muscle Velocity Recovery Cycles to Examine Muscle Membrane Properties
08:27

Muscle Velocity Recovery Cycles to Examine Muscle Membrane Properties

Published on: February 19, 2020

14.4K

Area of Science:

  • Investigates the complex nature of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
  • Explores the pathological processes underlying ME/CFS.
  • Addresses the significant impact of ME/CFS on patients and families.

Background:

  • Highlights the widespread disbelief and lack of understanding of ME/CFS among medical professionals.
  • Discusses the formation of new organizations like Doctors with ME and EUROMENE to tackle ME/CFS challenges.
  • Examines the difficulties in diagnosing ME/CFS and its associated care costs.

Discussion:

  • Compares ME/CFS with COVID-19, noting symptom overlap and proposing a new taxonomic category, post-active phase of infection syndromes (PAPIS).
  • Reports on the severe impact on quality of life for patients and families across European countries.
  • Considers international guidance and challenges in the UK regarding ME/CFS guidelines.

Key Insights:

  • Emphasizes the need for a person-centered approach to care, including mind-body interventions.
  • Presents evidence on the cost-effectiveness of ME/CFS interventions.
  • Underscores the importance of early detection and diagnosis for secondary prevention of ME/CFS.

Outlook:

  • Suggests that early detection and diagnosis can significantly reduce the population burden of ME/CFS.
  • Advocates for improved understanding and management strategies for ME/CFS.
  • Recommends further research into post-infection syndromes and their management.